Phenylacetic Acid Stimulates Reactive Oxygen Species Generation and Tumor Necrosis Factor-α Secretion in Vascular Endothelial Cells

Therapeutic Apheresis and Dialysis

Volumn 15, Issue 2, 2011, Pages 147-150

  Morita, Miwa ^a   Yano, Shozo ^a   Yamaguchi, Toru ^a   Yamauchi, Mika ^a   Sugimoto, Toshitsugu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Chronic renal failure; Oxidative stress; Tumor necrosis factor ; Uremic toxin; Vascular endothelium

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; PHENYLACETIC ACID; REACTIVE OXYGEN METABOLITE; TEMPOL; TUMOR NECROSIS FACTOR ALPHA;

AORTA; ARTICLE; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OXIDATIVE STRESS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

AORTA; CELLS, CULTURED; DEOXYGUANOSINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KIDNEY FAILURE, CHRONIC; OXIDATIVE STRESS; PHENYLACETATES; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79953059077     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2010.00887.x     Document Type: Article

References (18)

1. Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 2008;19:213-16.
2. Schoppet M, Shroff RC, Hofbauer LC, Shanahan CM. Exploring the biology of vascular calcification in chronic kidney disease: what's circulating? Kidney Int 2008;73:384-90.
3. Chen NX, Duan D, O'Neill KD etal. The mechanisms of uremic serum-induced expression of bone matrix proteins in bovine vascular smooth muscle cells. Kidney Int 2006;70:1046-53.
4. Pecovnik-Balon B. Cardiovascular calcification in patients with end-stage renal disease. Ther Apher Dial 2005;9:208-10.
5. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000;102:2636-42.
6. Al-Aly Z. Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy. Transl Res 2008;151:233-9.
7. Lee HL, Woo KM, Ryoo HM, Baek JH. Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction. Biochem Biophys Res Commun 2009;391:1087-92.
8. Zhang C, Xu X, Potter BJ etal. TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2006;26:475-80.
9. Vanholder R, De Smet R, Glorieux G etal. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003;63:1934-43.
10. Dou L, Jourde-Chiche N, Faure V etal. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J Thromb Haemost 2007;5:1302-8.
11. Jankowski J, van der Giet M, Jankowski V etal. Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest 2003;112:256-64.
12. Yano S, Yamaguchi T, Kanazawa I etal. The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failure. Nephrol Dial Transplant 2007;22:3160-5.
13. Iwasaki-Ishizuka Y, Yamato H, Nii-Kono T, Kurokawa K, Fukagawa M. Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone. Nephrol Dial Transplant 2005;20:1904-11.
14. Dou L, Bertrand E, Cerini C etal. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 2004;65:442-51.
15. Yamamoto H, Tsuruoka S, Ioka T etal. Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int 2006;69:1780-5.
16. Muteliefu G, Enomoto A, Jiang P, Takahashi M, Niwa T. Indoxyl sulphate induces oxidative stress and the expression of osteoblast-specific proteins in vascular smooth muscle cells. Nephrol Dial Transplant 2009;24:2051-8.
17. Adijiang A, Goto S, Uramoto S, Nishijima F, Niwa T. Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrol Dial Transplant 2008;23:1892-901.
18. Barreto FC, Barreto DV, Liabeuf S etal. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009;4:1551-8.